Arctic Bioscience Valuation
| ABS Stock | NOK 1.86 0.08 4.12% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Arctic Bioscience shows a prevailing Real Value of 1.86 per share. The current price of the firm is 1.86. Our model approximates the value of Arctic Bioscience from analyzing the firm fundamentals such as return on equity of -0.22, and Profit Margin of (1.98) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Arctic Bioscience's price fluctuation is abnormally volatile at this time. Calculation of the real value of Arctic Bioscience is based on 3 months time horizon. Increasing Arctic Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Arctic stock is determined by what a typical buyer is willing to pay for full or partial control of Arctic Bioscience AS. Since Arctic Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arctic Stock. However, Arctic Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.86 | Real 1.86 | Hype 1.94 |
The intrinsic value of Arctic Bioscience's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Arctic Bioscience's stock price.
Estimating the potential upside or downside of Arctic Bioscience AS helps investors to forecast how Arctic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arctic Bioscience more accurately as focusing exclusively on Arctic Bioscience's fundamentals will not take into account other important factors: Arctic Bioscience Total Value Analysis
Arctic Bioscience AS is presently projected to have takeover price of 145.21 M with market capitalization of 276.66 M, debt of 0, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Arctic Bioscience fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
145.21 M | 276.66 M | 0 |
Arctic Bioscience Investor Information
About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Arctic Bioscience recorded a loss per share of 1.75. The entity had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Arctic Bioscience's historical financial statements, Arctic Bioscience AS is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Arctic Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Arctic Bioscience has an asset utilization ratio of 6.3 percent. This suggests that the Company is making 0.063 for each dollar of assets. An increasing asset utilization means that Arctic Bioscience AS is more efficient with each dollar of assets it utilizes for everyday operations.Arctic Bioscience Ownership Allocation
Arctic Bioscience holds a total of 24.38 Million outstanding shares. Arctic Bioscience AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Arctic Bioscience Profitability Analysis
The company reported the revenue of 21.52 M. Net Loss for the year was (42.58 M) with profit before overhead, payroll, taxes, and interest of 5.8 M.About Arctic Bioscience Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Arctic Bioscience AS. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Arctic Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Arctic Bioscience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Arctic Bioscience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arctic Bioscience. We calculate exposure to Arctic Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Arctic Bioscience's related companies.Arctic Bioscience AS, a biotechnology company, provides nutraceutical and pharmaceutical products. Arctic Bioscience AS was incorporated in 2011 and is based in rsta, Norway. ARCTIC BIOSCIENCE is traded on Oslo Stock Exchange in Norway.
8 Steps to conduct Arctic Bioscience's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Arctic Bioscience's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Arctic Bioscience's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Arctic Bioscience's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Arctic Bioscience's revenue streams: Identify Arctic Bioscience's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Arctic Bioscience's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Arctic Bioscience's growth potential: Evaluate Arctic Bioscience's management, business model, and growth potential.
- Determine Arctic Bioscience's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Arctic Bioscience's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Arctic Stock
Arctic Bioscience financial ratios help investors to determine whether Arctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arctic with respect to the benefits of owning Arctic Bioscience security.